BioSec, Fujitsu team up to provide palm vein recognition to EMEIA
Under the agreement, Fujitsu’s product portfolio will now include BioSec’s palm vein recognition security solutions including physical access control, IT security, and stadium security solutions.
Fujitsu will sell BioSec solutions in the EMEIA region, where there is a significant interest for advanced security technology such as biometrics.
“The future’s security is in our hands, more precisely in our veins, as our vein pattern is an absolutely unique physical characteristics, which provides a perfect “material” for secure authentication,” BioSec said. “As people are getting more familiar with biometric solutions, they see that there is great difference between technologies. Even fingerprint recognition is the most widely adopted technology currently, it is not necessarily the most secure one. There is no 100 percent security solution of course, but palm vein recognition is quite close to it.”
BioSec has been developing biometric solutions based on Fujitsu’s PalmSecure technology for nearly a decade, combining high security with convenience.
In 2014, BioSec installed its palm vein authentication system at the 23,500-seat Hungarian Groupama Arena, which effectively put an end to the football spectator violence that would occasionally occur.